Implications of edge cases for antimicrobial susceptibility predictions for rifampin, delamanid, and pretomanid with the WHO Mycobacterium tuberculosis mutation catalog.
Overview & Synopsis
Open access biomedical research article published in Microbiol Spectr.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Implications of edge cases for antimicrobial susceptibility predictions for rifampin, delamanid, and pretomanid with the WHO Mycobacterium tuberculosis mutation catalog. |
|---|---|
| Author / Organization | Hermans N, Phelan J, Sorrentino R, Boysen F, Sherry NL, Miotto P, Cirillo DM, Chindelevitch L, Rodwell TC, Barilar I, Niemann S, Andres S, Mischnik A, Horan K, Bond K, Globan M, Rubinstein M, Losev Y, Clark TG, Mitarai S, Iskakova A, Slyzkyi A, Köser CU, Kremer K, Anthony R |
| Subject & Discipline | Microbiol Spectr |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-70019 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |